Literature DB >> 18952764

Thyroid cancer: is the incidence rise abating?

Geneviève Sassolas1, Zakia Hafdi-Nejjari, Laurent Remontet, Nadine Bossard, Aurélien Belot, Nicole Berger-Dutrieux, Myriam Decaussin-Petrucci, Claire Bournaud, Jean Louis Peix, Jacques Orgiazzi, Françoise Borson-Chazot.   

Abstract

OBJECTIVE: The aim of the present study was to determine recent trends in thyroid cancer incidence rates and to analyze histopathological characteristics and geographical distribution.
METHODS: Histologically proven 5367 cases were collected over the period 1998-2006 in France from the Rhône-Alpes thyroid cancer registry. Geographical variations of incidence were analyzed using a mixed Poisson model.
RESULTS: The average incidence rates, age standardized to the world population, were 3.9/100,000 in men and 12.3/100,000 in women, higher than those previously reported in France. After an initial increase during the first 3 years, a steady level of incidence was observed for the period 2001-2006. The annual incidence rate of microcarcinomas was correlated with that of all cancers in men and women (r=0.78 and 0.89; P<0.01) respectively. Papillary microcarcinomas represented 38% of tumors and two-thirds of them measured less than 5 mm in diameter. They were fortuitously discovered after thyroidectomy for benign diseases in 64% of cases. Histological marks of aggressiveness differed according to the size of the tumor. Despite recent advances in diagnosis, 13% of tumors were diagnosed at advanced stage especially in men. Geographical distribution of incidence based on subregional administrative entities showed lower incidence rates in rural than in urban zones in men (relative rate: 0.72; 95% CI: 0.62-0.84) and women (relative rate: 0.85; 95% CI: 0.73-0.93).
CONCLUSION: The present study suggests that the rise in thyroid cancer incidence is now abating. It could reflect standardization in diagnostic procedures. Further studies, performed on a more prolonged period, are necessary to confirm these data.

Entities:  

Mesh:

Year:  2008        PMID: 18952764     DOI: 10.1530/EJE-08-0624

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Incidental detection, imaging modalities and temporal trends of differentiated thyroid cancer in Ontario: a population-based retrospective cohort study.

Authors:  Todd A Norwood; Emmalin Buajitti; Lorraine L Lipscombe; Thérèse A Stukel; Laura C Rosella
Journal:  CMAJ Open       Date:  2020-11-02

2.  Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.

Authors:  C Lu; X Zhu; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

3.  Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients.

Authors:  Rudolf Hoermann; John E M Midgley; Johannes W Dietrich; Rolf Larisch
Journal:  Ther Adv Endocrinol Metab       Date:  2017-07-13       Impact factor: 3.565

Review 4.  Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup.

Authors:  Gilles Russ; Sophie Leboulleux; Laurence Leenhardt; Laszlo Hegedüs
Journal:  Eur Thyroid J       Date:  2014-09-05

5.  Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution.

Authors:  Carles Zafon; Juan Antonio Baena; Josep Castellví; Gabriel Obiols; Oscar Gonzalez; José Manuel Fort; Ramon Vilallonga; Enric Caubet; Manuel Armengol; Jordi Mesa
Journal:  Eur Thyroid J       Date:  2014-08-29

6.  Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor".

Authors:  Pasqualino Malandrino; Claudia Scollo; Ilenia Marturano; Marco Russo; Martina Tavarelli; Marco Attard; Pierina Richiusa; Maria Antonia Violi; Gabriella Dardanoni; Riccardo Vigneri; Gabriella Pellegriti
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-04       Impact factor: 5.555

7.  [Thyroid carcinoma: epidemiological, clinical and therapeutic profiles, about 102 cases].

Authors:  Mohamed Mliha Touati; Abdelfettah Aljalil; Youssef Darouassi; Mehdi Chihani; Mohammed Lahkim; Jawad Al Fassi Fihri; Brahim Bouaity; Haddou Ammar
Journal:  Pan Afr Med J       Date:  2015-05-26

Review 8.  Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections.

Authors:  Gilles Russ
Journal:  Ultrasonography       Date:  2015-07-13

9.  Investigation of thyroid nodules in the female population in Cyprus and in Romania.

Authors:  Andra Piciu; Xanthi D Andrianou; Alexandru Irimie; Ovidiu Bălăcescu; Christina Zira; Elena BĂRBUş; Claudiu Peştean; Kyriakos Aristeidou; Thalia Theofanous; Margerita Agathokleous; Doina Piciu; Konstantinos C Makris
Journal:  Clujul Med       Date:  2015-11-15

10.  Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.

Authors:  Jes Sloth Mathiesen; Jens Peter Kroustrup; Peter Vestergaard; Kirstine Stochholm; Per Løgstrup Poulsen; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Sten Schytte; Stefano Christian Londero; Henrik Baymler Pedersen; Christoffer Holst Hahn; Bjarki Ditlev Djurhuus; Jens Bentzen; Sören Möller; Mette Gaustadnes; Maria Rossing; Finn Cilius Nielsen; Kim Brixen; Anja Lisbeth Frederiksen; Christian Godballe
Journal:  Endocr Connect       Date:  2018-05-14       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.